A LinkedIn post from Tobin Scientific indicates that members of the company’s team plan to attend the Pharma USA conference in Philadelphia on March 16–17. The post names three representatives—Nikky Sunyar, Zack Newman, and Steve Yankanich—and suggests they will be available to discuss the firm’s offerings with attendees.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post positions this conference presence as an opportunity to engage with peers across the life sciences, biotech, and pharmaceutical sectors. For investors, Tobin Scientific’s participation may signal an effort to deepen relationships with industry stakeholders, potentially supporting future business development and reinforcing its visibility within the life sciences logistics and services ecosystem.